Sacituzumab govitecan and stereotactic radiosurgery in the management of HER2 negative breast cancer brain metastases: a multi-institutional report.

Khatri VM, Mestres-Villanueva MA, Daniel S, Yarlagadda S, Doniparthi A, Upadhyay R, Mills MN, Oliver DE, Yu HM, Palmer JD, Stover DG, Williams NO, Mahtani RL, Ahluwalia MS, Soyano AE, Soliman HH, Han HS, Kotecha R, Beyer SJ, Ahmed KA

Open source

DOI
10.1007/s11060-025-05230-7
Published
2025 Dec
Container
Journal of neuro-oncology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s11060-025-05230-7,
  title = {Sacituzumab govitecan and stereotactic radiosurgery in the management of HER2 negative breast cancer brain metastases: a multi-institutional report.},
  author = {Khatri VM and Mestres-Villanueva MA and Daniel S and Yarlagadda S and Doniparthi A and Upadhyay R and Mills MN and Oliver DE and Yu HM and Palmer JD and Stover DG and Williams NO and Mahtani RL and Ahluwalia MS and Soyano AE and Soliman HH and Han HS and Kotecha R and Beyer SJ and Ahmed KA},
  year = {2025},
  journal = {Journal of neuro-oncology},
  doi = {10.1007/s11060-025-05230-7},
  url = {https://doi.org/10.1007/s11060-025-05230-7}
}

RIS

TY  - JOUR
TI  - Sacituzumab govitecan and stereotactic radiosurgery in the management of HER2 negative breast cancer brain metastases: a multi-institutional report.
AU  - Khatri VM
AU  - Mestres-Villanueva MA
AU  - Daniel S
AU  - Yarlagadda S
AU  - Doniparthi A
AU  - Upadhyay R
AU  - Mills MN
AU  - Oliver DE
AU  - Yu HM
AU  - Palmer JD
AU  - Stover DG
AU  - Williams NO
AU  - Mahtani RL
AU  - Ahluwalia MS
AU  - Soyano AE
AU  - Soliman HH
AU  - Han HS
AU  - Kotecha R
AU  - Beyer SJ
AU  - Ahmed KA
PY  - 2025
JO  - Journal of neuro-oncology
DO  - 10.1007/s11060-025-05230-7
UR  - https://doi.org/10.1007/s11060-025-05230-7
ER  - 

APA

VM, K., MA, M., S, D., S, Y., A, D., R, U., MN, M., DE, O., HM, Y., JD, P., DG, S., NO, W., RL, M., MS, A., AE, S., HH, S., HS, H., R, K., SJ, B., & KA, A. (2025). Sacituzumab govitecan and stereotactic radiosurgery in the management of HER2 negative breast cancer brain metastases: a multi-institutional report.. Journal of neuro-oncology. https://doi.org/10.1007/s11060-025-05230-7

Source records